Aytu BioPharma Files Definitive Proxy Statement
Ticker: AYTU · Form: DEF 14A · Filed: Mar 28, 2025 · CIK: 1385818
| Field | Detail |
|---|---|
| Company | Aytu Biopharma, Inc (AYTU) |
| Form Type | DEF 14A |
| Filed Date | Mar 28, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, governance, shareholder-meeting
Related Tickers: AYTU
TL;DR
AYTU proxy filed - vote on directors & pay at May 21 meeting.
AI Summary
AYTU BIOPHARMA, INC. filed its definitive proxy statement on March 28, 2025, for its annual meeting on May 21, 2025. The filing outlines the company's governance and proposals for shareholders, including the election of directors and executive compensation.
Why It Matters
This filing provides shareholders with crucial information regarding company leadership, voting matters, and executive compensation, enabling informed participation in corporate governance.
Risk Assessment
Risk Level: low — This is a routine proxy filing providing information to shareholders and does not inherently present new risks.
Key Numbers
- 20250521 — Annual Meeting Date (Shareholders will vote on proposals at this date.)
Key Players & Entities
- AYTU BIOPHARMA, INC. (company) — Registrant
- 20250328 (date) — Filing Date
- 20250521 (date) — Annual Meeting Date
FAQ
What is the purpose of a DEF 14A filing?
A DEF 14A filing, or definitive proxy statement, is used by companies to solicit shareholder votes on important corporate matters, such as the election of directors and executive compensation.
When is AYTU BIOPHARMA, INC.'s annual meeting scheduled?
The annual meeting for AYTU BIOPHARMA, INC. is scheduled for May 21, 2025.
Who is the filer of this proxy statement?
The filer of this proxy statement is AYTU BIOPHARMA, INC.
What is the filing date of this definitive proxy statement?
The definitive proxy statement was filed on March 28, 2025.
What are the typical items voted on during an annual shareholder meeting as indicated by this filing type?
Typical items voted on include the election of directors and matters related to executive compensation.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on March 28, 2025 regarding AYTU BIOPHARMA, INC (AYTU).